Mr. Arvind Nanda
Joint Managing Director
Mentha & Allied Products Private Ltd.
16th Km Rampur-Swar Road
Rampur 244901
Uttar Pradesh
IndiaFEI 3004293613Issued Apr 16, 2025Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3004293613.
Violations5
Issue DateApr 16, 2025
Product TypeDrugs
StatusOpen
Letter Details
Firm
Mentha & Allied Products Private Ltd.
Location
Mr. Arvind Nanda
Joint Managing Director
Mentha & Allied Products Private Ltd.
16th Km Rampur-Swar Road
Rampur 244901
Uttar Pradesh
India
FEI Number
3004293613
Country
India
Issue Date
April 16, 2025
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Summary
Mentha & Allied Products Private Ltd., an Indian API manufacturer, was cited for significant Current Good Manufacturing Practice (CGMP) violations that rendered their active pharmaceutical ingredients adulterated. FDA inspectors found critical deficiencies including failure to maintain facility sanitation (soiled washrooms lacking soap, dirty gowning areas), use of visibly soiled cloth gloves without documented cleaning procedures, and inadequate equipment cleaning and maintenance procedures. The company's December 2024 response to the FDA Form 483 was determined inadequate due to lack of supporting documentation and insufficient evidence of corrective actions to achieve CGMP compliance.
Mentha & Allied Products Private Ltd. FDA Warning Letter, April 16, 2025